Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 10, 2012, Pages

  Zueger, Thomas ^a   Kirchner, Paul ^a   Herren, Coline ^a   Fischli, Stefan ^c   Zwahlen, Marcel ^b   Christ, Emanuel ^a   Stettler, Christoph ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Kantonsspital Lucerne   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; AGE; ARTICLE; BODY WEIGHT; BRAIN SURGERY; CANCER SURGERY; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DOSE CALCULATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONFUNCTIONING PITUITARY ADENOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ADENOMA; ADULT; AGED; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PITUITARY-ADRENAL SYSTEM; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84867270000     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2432     Document Type: Article

References (14)

1. Rosén T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288 (Pubitemid 20229130)
2. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431
3. Filipsson H, Monson JP, Koltowska-Häggström M, Mattsson A, Johannsson G 2006 The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954-3961 (Pubitemid 44536870)
4. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, Loriaux DL 1991 Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 72:39-45 (Pubitemid 21921653)
5. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD 1993 Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76:1505-1510 (Pubitemid 23164369)
6. Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM 2009 ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 94:4216-4223
7. Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT, Ross RJ 2004 Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 61:367-375 (Pubitemid 39287067)
8. Hagg E, Asplund K, Lithner F 1987 Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol (Oxf) 26:221-226 (Pubitemid 17015709)
9. Nieman LK 2003 Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest 26:74-82
10. Schimmer BP, Parker KL2006 Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormone. In: Brunton LL, Lazo J, Parker KL. Goodman and Gilman's the pharmacological basis of therapeutics. 11th ed.NewYork:McGrawHill; 1587-1612
11. Nielsen EH, Lindholm J, Laurberg P 2007 Excess mortality in women with pituitary disease: a meta-analysis. Clin Endocrinol (Oxf) 67:693-697 (Pubitemid 47620433)
12. Kaplan EL, Meier P 1958 Nonparametric Estimation from Incomplete Observations. J Am Stat Assoc 53:457-481
13. Crown A, Lightman S 2005 Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf) 63:483-492 (Pubitemid 41626741)
14. Debono M, Ross RJ, Newell-Price J 2009 Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol 160:719-729